The Offering was conducted through a syndicate of underwriters led by Morgan Stanley and Evercore ISI as co-lead book-running managers and included BMO Capital Markets, as a book-running manager, ...
18m
BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase
In addition, the Company has authorized, subject to the completion of the offering, the concurrent purchase from the underwriter, out of the 15,000,000 shares of common stock being sold as part of the ...
Discover the pros and cons of WesBanco, Inc.'s new preferred stock WSBCO vs peers. Click to get expert analysis and insights ...
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing ...
Oncolytics Biotech® Inc. (NASDAQ: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing ...
Evolve Funds Group Inc. (“Evolve”) is pleased to announce the distribution amounts per unit (the “Distributions”) for certain funds ...
After well-publicized protests of some of its works, 2024 turned out to be the last year at East Tennessee State University ...
Reitar Logtech Holdings receives a Strong Sell rating due to extreme risk factors and deteriorating fundamentals. Learn more ...
NEW YORK CITY, NEW YORK / ACCESS Newswire / October 20, 2025 / On October 17, 2025, Vivakor, Inc. ("Vivakor" or the "Company") (NASDAQ:VIVK), an integrated energy infrastructure and environmental serv ...
$125 Million in Upfront Proceeds Expected to Fund Next Phase of Cemsidomide Multiple Myeloma Development Including Registrational Phase 2 Trial in Combination with Dexamethasone and Phase 1b Trial in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback